share_log

Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024

Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024

MIRA制药早前报告:将在2024年10月28-29日于波士顿举行的第18届疼痛治疗峰会上展示新的临床前数据,显示Ketamir-2对神经病性疼痛的100%逆转。
Benzinga ·  09/27 14:50

Reported Earlier: MIRA Pharmaceuticals To Present New Preclinical Data Showing 100% Reversal Of Neuropathic Pain For Ketamir-2 At 18th Annual Pain Therapeutics Summit In Boston On October 28-29, 2024

此前报道:MIRA Pharmicals将于2024年10月28日至29日在波士顿举行的第18届年度疼痛疗法峰会上公布新的临床前数据,显示Ketamir-2的神经病理性疼痛可100%逆转

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发